Eli Lilly has launched a first-of-its-kind website, LillyDirect, that allows patients to access popular weight loss medications like Mounjaro and Zepbound more easily.

Through partnerships with telehealth providers, the platform enables medical evaluations and prescriptions. Once prescribed, the medications are then directly delivered to the patient’s home through affiliated pharmacy services.

This new direct-to-patient prescription and delivery model aims to simplify and streamline obtaining these high-demand treatments, removing barriers of transportation, access, and convenience for those eligible.

How It Will Work

The service is open to patients who have a body mass index (BMI) of at least 30, which falls within the obesity range, or a BMI of at least 27 if they also have at least one other weight-related condition. Patients with BMIs between 25 and 29.9 are considered overweight. LillyDirect also serves patients with diabetes and migraines.

Read Full Article Here